Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameAdvisory Committee of the USAID Malaria Vaccine Development ProgramAgency NameAgency for International Development
Fiscal Year2002Committee Number1056
Original Establishment Date11/27/1989Committee StatusTerminated
Actual Termination Date12/30/2001Committee URL 
New Committee This FYNoPresidential Appointments*No
Terminated This FYYesMax Number of Members*10
Current Charter Date12/30/1999Designated Fed Officer Position Title*DFO
Date Of Renewal Charter12/31/2001Designated Federal Officer PrefixDr.
Projected Termination Date12/30/2001Designated Federal Officer First Name*Carter
Exempt From Renewal*NoDesignated Federal Officer Middle NameL.
Specific Termination AuthorityDesignated Federal Officer Last Name*Diggs
Establishment Authority*Agency AuthorityDesignated Federal Officer Suffix
Specific Establishment Authority*AGENDesignated Federal Officer Phone*(202) 712-5728
Effective Date Of Authority*8/6/1997Designated Federal Officer Fax*(202) 216-3702
Committee Type*ContinuingDesignated Federal Officer Email*cdiggs@usaid.gov
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Terminate
Legislation to Terminate RequiredNo
Legislation Status 
How does cmte accomplish its purpose?*The committee reviews malaria vaccine development progress and plans on a semi-annual or annual basis. Following an extensive review of data and progress presented by MVDP staff or collaborators, the committee deliberates and makes recommendations on specific approaches to malaria vaccine development, which are then incorporated into the plans as appropriate.
How is membership balanced?*The committee includes members with experience in industry and academia, and with expertise in vaccine development, malariology, immunology, molecular biology, and clinical evaluation of vaccines. Both broad and specific technical advice is therefore available.
How frequent & relevant are cmte mtgs?*The meetings are held semi-annually or annually to provide the necessary oversight to ensure the continuing appropriate conduct of the program. The MVDP staff sets the agenda in consultation with the committee chairman and members and invites collaborators to present recent work. As such, the committee is presented with the most relevant and up-to-date information on which to make their recommendations.
Why advice can't be obtained elsewhere?*The committee is necessary to provide the requisite transparency and credibility to the process. Also, the MVDP staff value the committee's broad experience in all fields of malaria vaccine development and rely on the committee members for assistance in planning program direction.
Why close or partially close meetings?Portions of the meetings may be closed so that any issues pertaining to budget and procurement can be discussed openly.
Recommendation Remarks
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety* Action Reorganize Priorities* 
Outcome Trust In Government Action Reallocate Resources 
Outcome Major Policy Changes Action Issued New Regulations 
Outcome Advance In Scientific Research Action Proposed Legislation 
Outcome Effective Grant Making Action Approved Grants Or Other Payments 
Outcome Improved Service Delivery Action Other 
Outcome Increased Customer Satisfaction Action Comment
Outcome Implement Laws/Reg Requirements Grants Review* 
Outcome Other Number Of Grants Reviewed 
Outcome CommentNumber Of Grants Recommended 
Cost Savings* Dollar Value Of Grants Recommended 
Cost Savings CommentGrants Review Comment
Number Of Recommendations* Access Contact Designated Fed. Officer* 
Number Of Recommendations CommentAccess Agency Website 
% of Recs Fully Implemented* Access Committee Website 
% of Recs Fully Implemented CommentAccess GSA FACA Website 
% of Recs Partially Implemented* Access Publications 
% of Recs Partially Implemented CommentAccess Other 
Agency Feedback* Access Comment
Agency Feedback CommentNarrative Description*
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$4,631.00Estimated Payments to Federal Staff*$0.00
Payments to Consultants*$3,014.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$25,000.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$1,800.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$4,000.00Est. Other Costs Next FY*$0.00
Total Costs$38,445.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)*0.30Est. Fed Staff Support Next FY*0.00
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

  
ActionCommittee System IDCommittee NameFiscal Year
 COM-017239Advisory Committee of the USAID Malaria Vaccine Development Program2001
 COM-019118Advisory Committee of the USAID Malaria Vaccine Development Program2000
 COM-019194Advisory Committee of the USAID Malaria Vaccine Development Program1999
 COM-020151Advisory Committee of the USAID Malaria Vaccine Development Program1998
 COM-021927Advisory Committee of the USAID Malaria Vaccine Development Program1997